Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis

• Published in: BMC gastroenterology Vol. 19; no. 1; pp. 51 - 11
• Main Authors: Pu, Ke, Wang, Yuping, Bai, Suyang, Wei, Hui, Zhou, Yongning, Fan, Jiangao, Qiao, Liang
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 08.04.2019; BioMed Central; BMC
• Subjects: Accuracy; Biopsy; Body mass index; Controlled attenuation parameter (CAP); Data processing; Diagnosis; Elasticity Imaging Techniques - methods; Enzymes; Fatty liver; Gastroenterology; Hepatic steatosis, diagnostic accuracy; Hepatocellular carcinoma; Humans; Liver diseases; Medical imaging; Medical research; Meta-analysis; NMR; Non-alcoholic fatty liver disease (NAFLD); Non-alcoholic Fatty Liver Disease - diagnostic imaging; Non-alcoholic Fatty Liver Disease - pathology; Nuclear magnetic resonance; Risk factors; ROC Curve; Sensitivity and Specificity; Steatosis; Studies; Systematic review; Transient elastography; Ultrasonic imaging; China; Hepatic steatosis, diagnostic accuracy; Transient elastography; Controlled attenuation parameter (CAP); Non-alcoholic fatty liver disease (NAFLD)

Controlled attenuation parameter (CAP) is a non-invasive method for diagnosing hepatic steatosis. Despite good diagnostic performance, clinical application of CAP is limited due to the influences of covariates. Here, a systematic review on the performance of CAP in the diagnosis and staging of hepat...